Atlas Trials

Kiadis Pharma

10 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Kiadis Pharma

RecordFirmDate
Off-the-shelf NK Cells (KDS-1000) as Immunotherapy for COVID-19 (NCT04797975)Kiadis Pharma2020-12-01
Haplo-identical Natural Killer (NK) Cells to Prevent Post-Transplant Relapse in AML and MDS (NK-REALM) (NCT04395092)Kiadis Pharma2020-11-13
Safety and Efficacy of ATIR101 as Adjunctive Treatment to Blood Stem Cell Transplantation From a Haploidentical Family Donor Compared to Post-transplant Cyclophosphamide in Patients With Blood Cancer (NCT02999854)Kiadis Pharma2017-11-29

Track Kiadis Pharma automatically

Every clearance here is in the API, with alerts when new ones post.